| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/06/2013 | EP2563920A1 Modulation of transthyretin expression |
| 03/06/2013 | EP2563902A1 Improved glycosylation of proteins in host cells |
| 03/06/2013 | EP2563802A1 Compositions and methods for the modification of gene transcription |
| 03/06/2013 | CN102959087A Compositions for linking zinc finger modules |
| 03/05/2013 | US8389806 Vascular-preferred promoters |
| 03/05/2013 | US8389805 Promoter, promoter control elements, and combinations, and uses thereof |
| 03/05/2013 | US8389795 Transgenic cells for use as bioreactors; heterologous gene expression; animal model of disease |
| 03/05/2013 | US8389711 Pharmaceutical composition for treatment of cancer and asthma |
| 03/05/2013 | US8389710 Therapeutic nucleic acid-3′-conjugates |
| 03/05/2013 | US8389709 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 03/05/2013 | US8389708 Method of cancer treatment using siRNA silencing |
| 03/05/2013 | US8389707 Oligonucleotides related to lipid membrane attachments |
| 03/05/2013 | US8389706 Vaccines for human papilloma virus and methods for using the same |
| 03/05/2013 | US8389705 Nitrate transport components |
| 03/05/2013 | US8389704 Binding members for IgE molecules |
| 03/05/2013 | US8389703 Ribonucleoside analogs with novel hydrogen bonding patterns |
| 03/05/2013 | US8389702 Multi-oligomeric or multi-polymeric compositions comprising labeled moieties and binding partners |
| 03/05/2013 | US8389701 Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners |
| 03/05/2013 | US8389700 Agent delivery system capable of selectively releasing an agent |
| 03/05/2013 | US8389699 Nucleic acid terminators incorporating a cationic moiety and methods for their use |
| 03/05/2013 | US8389685 Vector encoding a plasmid replication protein and use thereof |
| 03/05/2013 | US8389496 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/05/2013 | US8389495 Olioodeoxynucleotide and its use to induce an immune response |
| 03/05/2013 | US8389491 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
| 03/05/2013 | US8389489 Modulators of coagulation factors |
| 03/05/2013 | US8389488 Antidotes to antisense compounds |
| 03/05/2013 | US8389485 Encapsulated nanoparticles for nucleic acid delivery |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8389252 Yeast strain for production of four carbon alcohols |
| 03/05/2013 | US8389244 Methods and kits for synthesis of siRNA expression cassettes |
| 03/05/2013 | US8389242 Process for producing Apo2L |
| 03/05/2013 | US8389241 Enzyme that catalyzes a peptide-forming reaction from a carboxy component and an amine component, microbe producing the same, and a method of producing a dipeptide using the enzyme or microbe |
| 03/05/2013 | US8389238 Long-term in vivo transgene expression |
| 03/05/2013 | US8389221 Method of detecting H5 or H7 avian influenza virus |
| 03/05/2013 | US8389219 Detection of nucleic acids by type-specific hybrid capture method |
| 03/05/2013 | US8389218 Analysis of single nucleotide polymorphisms using a nicking endonuclease |
| 03/05/2013 | US8389217 Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS) |
| 03/05/2013 | US8389216 Methods for nucleic acid manipulation |
| 03/05/2013 | US8389215 Non-invasive recovery of RNA and analysis of gene expression in skin |
| 03/05/2013 | US8389212 Method for the electronic analysis of a sample oligonucleotide sequence |
| 03/05/2013 | US8389210 MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors |
| 03/05/2013 | US8388972 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 02/28/2013 | WO2013028701A1 Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity |
| 02/28/2013 | WO2013028643A1 Preparation of polynucleotides on a solid substrate for sequencing |
| 02/28/2013 | WO2013026142A1 Ionic tags for synthesis of oligoribonucleotides |
| 02/28/2013 | WO2013006345A3 Plants with improved agronomic traits |
| 02/28/2013 | WO2012177947A3 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes |
| 02/28/2013 | WO2012174476A3 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 02/28/2013 | WO2012162705A3 Cell and gene based methods to improve cardiac function |
| 02/28/2013 | WO2011154947A3 D5 desaturase-defective mutant gene and use thereof |
| 02/28/2013 | US20130055466 Methods and Compositions for Watermelon Firmness |
| 02/28/2013 | US20130053431 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 02/28/2013 | US20130053428 Natural antisense and non-coding rna transcripts as drug targets |
| 02/28/2013 | US20130053327 Polypeptide expressed in the stratum corneum and use thereof |
| 02/28/2013 | US20130053275 Methods and devices for predicting treatment efficacy |
| 02/28/2013 | US20130053271 Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies |
| 02/28/2013 | US20130053269 Primer Sequences for Amplification of Sea Otter Genes, and Methods of Use Thereof |
| 02/28/2013 | US20130053264 Mirna fingerprint in the diagnosis of prostate cancer |
| 02/28/2013 | US20130053254 Process for parallel isolation and/or purification of rna and dna |
| 02/28/2013 | US20130052699 Biocatalysts for ezetimibe synthesis |
| 02/28/2013 | US20130052690 Pcr primer and method for reducing non-specific nucleic acid amplification using a photolabile protecting group |
| 02/28/2013 | US20130052663 Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors |
| 02/28/2013 | US20130052654 Amyloid Precursor Protein E2 Domain and Uses Thereof |
| 02/28/2013 | US20130052229 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 02/28/2013 | US20130052222 Influenza nucleic acid molecules and vaccines made therefrom |
| 02/28/2013 | US20130052207 Prognostic Method for Pulmonary Adenocarcinoma, Pulmonary Adenocarcinoma Detection Kit, and Pharmaceutical Composition for Treating Pulmonary Adenocarcinoma |
| 02/28/2013 | US20130052205 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 02/28/2013 | US20130052176 Aptamer for ngf and use thereof |
| 02/28/2013 | US20130052157 Use of il-17e for cancer treatment |
| 02/28/2013 | US20130052131 Nanoparticles, methods of making nanoparticles, and methods of use |
| 02/28/2013 | CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof |
| 02/28/2013 | CA2844913A1 Integrated method for high-throughput identification of novel pesticidal compositions and uses therefor |
| 02/27/2013 | EP2562256A2 C5a binding nucleic acids |
| 02/27/2013 | EP2562188A2 Compositions and methods for diagnosing and treating cancer |
| 02/27/2013 | EP2561078A2 NOVEL STRUCTURALLY DESIGNED shRNAs |
| 02/27/2013 | EP2561075A2 Aav-based treatment of cholesterol-related disorders |
| 02/27/2013 | EP2560983A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 02/27/2013 | EP2560982A2 Phosphoramidites for synthetic rna in the reverse direction |
| 02/27/2013 | CN102943072A Method for protecting complementary DNA (deoxyribonucleic acid) by Morpholino |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN101018860B Flavivirus vaccine |
| 02/26/2013 | US8383890 Genes encoding fatty acid desaturases from Sorghum bicolor |
| 02/26/2013 | US8383807 MicroRNA and methods for inhibiting same |
| 02/26/2013 | US8383806 Method of reversing carboplatin resistance by inhibition of HGFIN |
| 02/26/2013 | US8383805 RNAi modulation of SCAP and therapeutic uses thereof |
| 02/26/2013 | US8383804 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof |
| 02/26/2013 | US8383803 PITX3 expression promoters |
| 02/26/2013 | US8383801 Polynucleotide encoding a sclerostin-binding antibody |
| 02/26/2013 | US8383799 Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
| 02/26/2013 | US8383798 Polynucleotide encoding a cellulase enzyme and method for producing the enzyme |
| 02/26/2013 | US8383797 Luciferase gene optimized for use in imaging of intracellular luminescence |
| 02/26/2013 | US8383796 Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1) |
| 02/26/2013 | US8383795 Detection and quantification of biomolecules using mass spectrometry |
| 02/26/2013 | US8383794 Conformation-selective nucleic acid inhibitors of AMPA glutamate receptors |
| 02/26/2013 | US8383793 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors |
| 02/26/2013 | US8383792 Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid |
| 02/26/2013 | US8383791 Oligonucleotides |
| 02/26/2013 | US8383790 Modified surface antigen |
| 02/26/2013 | US8383789 Vasopressin-binding L-nucleic acid |
| 02/26/2013 | US8383788 For therapy of cancer or tumorous growth |